相似文献
1
Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man.
Br J Pharmacol. 1969 Jun;36(2):368-72. doi: 10.1111/j.1476-5381.1969.tb09511.x.
2
The effects of a new beta-adrenoceptive receptor blocking drug on heart rate in man.
Br J Pharmacol Chemother. 1968 Mar;32(3):663-70. doi: 10.1111/j.1476-5381.1968.tb00465.x.
3
Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.
Br J Pharmacol. 1971 Sep;43(1):10-22. doi: 10.1111/j.1476-5381.1971.tb07152.x.
4
5
Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
Br J Pharmacol. 1970 May;38(3):546-53. doi: 10.1111/j.1476-5381.1970.tb10596.x.
6
Depression of isoprenaline-induced idioventricular rhythm in man by beta-adrenergic receptor blocking agents.
Acta Med Scand. 1968 May;183(5):401-6. doi: 10.1111/j.0954-6820.1968.tb10499.x.
7
Effect of a new adrenergic beta-blocking agent (ICI 50,172) on heart rate in relation to its blood levels.
Int Z Klin Pharmakol Ther Toxikol. 1968;1(6):467-74.
8
Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.
Br J Pharmacol. 1971 Nov;43(3):639-48. doi: 10.1111/j.1476-5381.1971.tb07193.x.
9
Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
Br J Pharmacol. 1973 Mar;47(3):621P-622P.
10
Comparison of propranolol and I.C.I. 50,172 on isoprenaline-induced increase in skin temperature in man.
Br J Pharmacol. 1969 May;36(1):177P-178P.
引用本文的文献
1
Effects of age and smoking on the pharmacokinetics of pindolol and propranolol.
Br J Clin Pharmacol. 1982;13(Suppl 2):217S-222S. doi: 10.1111/j.1365-2125.1982.tb01914.x.
2
The effect of the beta-adrenoceptor antagonist pindolol on exercise performance.
Br J Clin Pharmacol. 1982 May;13(5):723-7. doi: 10.1111/j.1365-2125.1982.tb01443.x.
3
Effect on heart rate over 24 hours of pindolol administered for 14 days.
Eur J Clin Pharmacol. 1984;27(5):535-8. doi: 10.1007/BF00556888.
4
Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?
Drugs. 1983 Apr;25(4):331-8. doi: 10.2165/00003495-198325040-00001.
5
Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.
Br J Clin Pharmacol. 1982;13(Suppl 2):187S-192S. doi: 10.1111/j.1365-2125.1982.tb01909.x.
6
Relative potency of intravenous prinodolol and propranolol in man.
Br J Pharmacol. 1971 Aug;42(4):665P-666P.
7
Comparison of propranolol and LB 46 (prinodolol) on hyperthyroid tachycardia.
Postgrad Med J. 1971 Jun;47(548):329-31. doi: 10.1136/pgmj.47.548.329.
8
Pharmacokinetics of pindolol in man.
Eur J Clin Pharmacol. 1974;7(1):17-24. doi: 10.1007/BF00614385.
9
Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.
Br J Pharmacol. 1971 Sep;43(1):10-22. doi: 10.1111/j.1476-5381.1971.tb07152.x.
10
Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
Br J Pharmacol. 1970 May;38(3):546-53. doi: 10.1111/j.1476-5381.1970.tb10596.x.
本文引用的文献
1
The effects of a new beta-adrenoceptive receptor blocking drug on heart rate in man.
Br J Pharmacol Chemother. 1968 Mar;32(3):663-70. doi: 10.1111/j.1476-5381.1968.tb00465.x.
Zotero 插件